Release Date: 21/02/19 13:52 Summary: Appendix 4D Half Year Report for period ending 31 Dec 2018 Price Sensitive: Yes Download Document 513.24KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status